Pyritinol

DB13084InvestigationalSmall molecule

Pyritinol is a vitamin B6 analog indicated as an adjunct therapy in the treatment of a wide variety of disorders of the brain. Pyritinol has been used in trials studying the treatment of Dementia, Depression, Schizophrenia, Anxiety Disorders, and Psychosomatic Disorders.

Chemical structure of Pyritinol
Formula / weight
C16H20N2O4S2 · 368.47 g/mol (avg)

Resolves to

Compound
UNIIAK5Q5FZH2RCAS1098-97-1ChEMBLCHEMBL488093ChEBI135554PubChem14190
Clinical / RWD
RxNorm9020ATCN06BX02
Structure
InChIKeySIXLXDIJGIWWFU-UHFFFAOYSA-NSMILESCC1=C(O)C(CO)=C(CSSCC2=C(CO)C(O)=C(C)N=C2)C=N1

What you can answer from here — as of August 30, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
2ContraindicationsEach with its own population and attribute set
Sign in
19Marketed productsAcross 3 countries and 8 labellers
Sign in
1ATC codeIncluding every combination product, plus 4 drug categories
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which other approved drugs treat the same conditions as Pyritinol, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In